bezafibrate has been researched along with prostaglandin d2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernando, R; Moorhead, JF; Powis, SH; Ruan, XZ; Varghese, Z; Wheeler, DC | 1 |
| Birtwistle, J; Bunce, CM; Davies, NJ; Delgado, J; Drayson, MT; Hayden, RE; Khanim, FL; Pearce, C; Pratt, G; Sant, T | 1 |
| Birtwistle, J; Bunce, CM; Davies, NJ; Drayson, MT; Green, RM; Gunther, UL; Hayden, RE; Khanim, FL; Lodi, A; Mountford, JC; Murray, JA; Ride, JP; Schrewe, H; Tiziani, S; Viant, MR | 1 |
3 other study(ies) available for bezafibrate and prostaglandin d2
| Article | Year |
|---|---|
PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway.
Topics: Anticholesteremic Agents; Antineoplastic Agents; ATP-Binding Cassette Transporters; Bezafibrate; Biological Transport; Cell Line, Transformed; Cholesterol; DNA-Binding Proteins; Glomerular Mesangium; Humans; Hydroxycholesterols; Hypolipidemic Agents; Interleukin-1; Liver X Receptors; Orphan Nuclear Receptors; Prostaglandin D2; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2003 |
Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2.
Topics: Apoptosis; Bezafibrate; CD40 Ligand; Cell Proliferation; Drug Combinations; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Medroxyprogesterone Acetate; Mitochondrial Proteins; Prostaglandin D2; Reactive Oxygen Species; Signal Transduction; Superoxides; Tumor Cells, Cultured | 2009 |
Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bezafibrate; Cell Differentiation; Cell Line, Tumor; Cholecalciferol; Drug Screening Assays, Antitumor; Glutathione; Humans; Hydroxyprostaglandin Dehydrogenases; I-kappa B Proteins; Leukemia, Myeloid, Acute; Medroxyprogesterone Acetate; PPAR gamma; Prostaglandin D2; Reactive Oxygen Species; Vitamin A | 2009 |